LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Global Sports Medicine Market Booming
Large Joints and Extremities

Global Sports Medicine Market Booming

July 10, 2012 1 min read Premium comments

Advertisement

Global Sports Medicine Market Booming
Source: Wikimedia Commons and BrokenSphere
Secondary

If the publication Official Wire, of London, England, is correct in its estimates, the global sports medicine implant market, valued at $1 billion in 2011, will grow to $1.6 billion by 2018. That is a compound annual growth rate (CAGR) of 6.7%.

The growth in the market is being predominantly driven by an increase in injury rates experienced by an aging population along with the more technologically advanced implant options.

The U.S. has the largest share of the sports medicine implants market, accounting for 49% of the global market last year. In 2011 the U.S. market value reached $517.8 million. By 2018 this value is forecast to reach $820 million, growing at a CAGR of 6.8%.

Among the advances in implant technology that are set to play a role in boosting the sports medicine implants market are the advantages of newer implants which enable easier post-operative imaging, revision surgery, and the enabling of bone formation within the screw.

Biodegradable implants are increasingly being used in the field of operative sports medicine. The report notes that, today, surgeons have available to them a tremendous variety of implants and devices such as interference screws, staples, sutures, tacks, suture anchors, and devices for meniscus repair.

Analysts also note that there is a growing preference for implants constructed from biocomposite materials, due to their greater perceived efficacy and safety when compared to traditional metal varieties.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy